Stocksigma LogoStocksigma Logo

Clinitech Laboratory Reports Nil Deviation in IPO Proceeds Utilization for Sep'26

Clinitech Laboratory Limited reported zero deviation or variation in the utilization of funds raised via its initial public offering for the quarter ended

Clinitech Laboratory Reports Nil Deviation in IPO Proceeds Utilization for Sep'26

Clinitech Laboratory Ltd 路 Others (Uncategorized) 路 13 Nov 2026, 8:27 pm

Clinitech Laboratory Reports Nil Deviation in IPO Proceeds Utilization for Sep'26 Clinitech Laboratory Limited reported zero deviation or variation in the utilization of funds raised via its initial public offering for the quarter ended 30th Sep'26. Out of total proceeds amounting to INR 578.30 Lakhs allotted on 30th Jul'24, the company has deployed INR 528.30 Lakhs, comprising INR 448.67 Lakhs toward diagnostic centre expansion (out of INR 498.67 Lakhs allocated), INR 41.33 Lakhs for general corporate purposes, and INR 38.30 Lakhs for issue expenses. Audit committee and auditor reviews noted no adverse comments.

Original exchange filing (PDF)

More announcements from Clinitech Laboratory Ltd

All Clinitech Laboratory Ltd announcements